ArticleScientific reports2025

PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma.

Zeinab A Elzanaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.